Related Articles
Knockdown of E2F5 induces cell death via the TP53‑dependent pathway in breast cancer cells carrying wild‑type TP53
NHERF1 inhibits proliferation of triple-negative breast cancer cells by suppressing GPER signaling
Overexpression of microRNA‑620 facilitates the resistance of triple negative breast cancer cells to gemcitabine treatment by targeting DCTD
Dual inhibition of EGFR and MET induces synthetic lethality in triple-negative breast cancer cells through downregulation of ribosomal protein S6
Breast cancer cells evade paclitaxel-induced cell death by developing resistance to dasatinib